Danish students visit NANBIOSIS Unit 28 at IBIMA-BIONAND to explore cutting-edge nanoimaging technologies driving innovation in biomedical research.
Málaga, October 2025 — A delegation of students from Denmark visited the NanoImaging Unit (U28), part of NANBIOSIS ICTS and embedded within IBIMA Plataforma BIONAND, for a hands-on introduction to its scientific and technical capabilities. This international exchange allowed them to engage with the facility’s staff, explore cutting-edge instrumentation, and see how nanoimaging plays a pivotal role in biomedical research and innovation in health.
During the visit, the students had the opportunity to observe demonstrations of imaging modalities, ask questions about preclinical and molecular imaging workflows, and gain insights into how these technologies accelerate research in nanomedicine. The exchange underscores the commitment of NANBIOSIS and IBIMA to nurture scientific vocations, facilitate knowledge transfer, and strengthen cross-European collaboration in health research.
About NANBIOSIS Unit 28
The NanoImaging Unit (U28) is hosted by IBIMA Plataforma BIONAND, at the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) in Málaga. It is accredited as a node of NANBIOSIS ICTS and offers advanced imaging services to internal and external users.
Core Capabilities & Departments
U28 is structured into four main technological areas, each supporting a specialized domain of biomedical nanoimaging:
- Small Animal Multimodal Imaging – includes MRI, in vivo bioluminescence and fluorescence imaging, and micro-CT for non-invasive preclinical studies.
- Magnetic Resonance (NMR) – equipped with a 400 MHz spectrometer for routine work and a 600 MHz instrument capable of HR-MAS (high-resolution magic angle spinning) and advanced in vitro analysis. Also includes a TD-NMR analyzer for relaxivity measurements.
- Electron Microscopy – offers TEM, Cryo-TEM, electron tomography, high-resolution SEM, and environmental SEM, with advanced sample preparation (e.g. cryo-immobilization) for biological and nanomedicine applications.
- Advanced Fluorescence / Optical Microscopy – includes confocal microscopy, multiphoton microscopy, super-resolution imaging, fluorescence imaging, and high content screening. Integration with other modalities supports comprehensive multimodal studies.
These capabilities enable U28 to support molecular imaging, structural and functional studies, characterization of nano-compounds, and preclinical evaluations. In addition, the NanoImaging Unit is closely linked to complementary facilities within BIONAND, including the Cell Culture Unit, Chemical Unit, Animal House (supporting rodents and zebrafish), and the Histology Unit (which provides advanced sectioning, including for hard materials).
As a recognized ICTS node, U28 contributes to the Spanish map of singular scientific and technical infrastructures, enabling high-level access to imaging technologies for national and international users. The Unit underpins translational nanomedicine research in Spain and Europe by providing cutting-edge instrumentation and expertise.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
